Cognition Therapeutics Expands Clinical Expertise on Medical Advisory Board with Addition of Drs. Mary Sano and Philip Scheltens
Press Release
, April 5th, 2019
Cognition Therapeutics Elects Lisa Ricciardi to its Board of Directors
Press Release
, March 26th, 2019
Carmell Therapeutics Announces Publication of Results of Pre-Clinical Studies on its Tissue Healing Accelerant for the Treatment of Cutaneous Radiation Injury
Press Release
, March 7th, 2019
Randy Hubbell speaks with Stock News Now at the BIO CEO & Investor Conference 2019 in New York
Press Release
, March 5th, 2019
Cognition Therapeutics Receives European Patent Covering its Alzheimer’s Disease Candidate, Elayta™
Press Release
, February 21st, 2019
First Patient Dosed in Complexa Phase 2 Trial of Lead Candidate CXA-10 to Treat Pulmonary Arterial Hypertension
Press Release
, February 21st, 2019
Cognition Therapeutics Announces Publication of Complete Results from Phase 1 Clinical Trial of Elayta™
Press Release
, February 19th, 2019
Carmell Therapeutics to Present at the 21st Annual BIO CEO & Investor Conference in New York
Press Release
, February 4th, 2019
ALung raises $5M
Pittsburgh Business Times
, January 9th, 2019
Wendy F. DiCicco joins Carmell Therapeutics’ Board of Directors
Press Release
, January 3rd, 2019